Physician

Daniel Lee Delo, MD

According to 2025 Medicare claims, Daniel Delo, MD (NPI: 1114128618) practices rheumatology in the Wilmington, NC market, with the plurality of this provider's patient population coming from New Hanover, NC. This provider's primary affiliated billing organization is CAROLINA ARTHRITIS ASSOCIATES, P.A. (NPI: 1427010081; TIN: 561745946) and primary practice location at 28401-6442. Delo is affiliated with the CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Delo's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 454 traditional Medicare patients, billed 225,731 HCPCS/CPT codes, and received $2,843,172 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,115 prescription claims across 299 beneficiaries totaling $1,288,496 in drug costs, led by Enbrel Sureclick (Etanercept). DME data shows 13 claims. Open Payments data shows 22 records totaling $447. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $55,999 to $2,843,172. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $841,788 and ending at $1,288,496. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.8M$3.6M2015 Medicare payment: $55,999 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $94,794 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $112,509 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,853,958 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,780,785 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $3,128,469 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $3,630,504 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $3,220,990 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,878,683 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,843,172 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20152632,813$55,999
201637010,687$94,794
20172895,096$112,509
2018402126,868$2,853,958
2019393152,707$2,780,785
2020459203,470$3,128,469
2021529227,270$3,630,504
2022511217,100$3,220,990
2023407228,062$2,878,683
2024454225,731$2,843,172

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$700K$1.4M2015 Drug cost: $841,788 (USD; Tot_Drug_Cst)2016 Drug cost: $1,326,711 (USD; Tot_Drug_Cst)2017 Drug cost: $1,016,836 (USD; Tot_Drug_Cst)2018 Drug cost: $766,835 (USD; Tot_Drug_Cst)2019 Drug cost: $1,088,937 (USD; Tot_Drug_Cst)2020 Drug cost: $1,291,377 (USD; Tot_Drug_Cst)2021 Drug cost: $1,399,507 (USD; Tot_Drug_Cst)2022 Drug cost: $1,076,546 (USD; Tot_Drug_Cst)2023 Drug cost: $1,083,832 (USD; Tot_Drug_Cst)2024 Drug cost: $1,288,496 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20155693,612$841,788
20165994,067$1,326,711
20174392,246$1,016,836
20183392,300$766,835
20193222,455$1,088,937
20203432,634$1,291,377
20213702,585$1,399,507
20223112,275$1,076,546
20232952,108$1,083,832
20242992,115$1,288,496

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$19K$39K2020 Medicare payment: $230 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $30,172 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $38,895 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/R12$230
2021N/RN/RN/R
2022N/R11$30,172
2023N/RN/RN/R
2024N/R13$38,895

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more3641,120$90
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's292712$12
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count3481,078$8
86140Measurement c-reactive protein for detection of infection or inflammation3351,033$5
82565Blood creatinine level290949$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Enbrel SureclickEtanercept391,372$365,833
PrivigenImmun Glob G(Igg)/Pro/Iga 0-5014392$209,249
Cyltezo(Cf) PenAdalimumab-Adbm14392$106,880
BenlystaBelimumab17476$89,586
Xeljanz XrTofacitinib Citrate12360$78,167

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
J1576Injection, immune globulin (panzyga), intravenous, non-lyophilized (e.g., liquid), 500 mgNN/R13$38,895

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.22$447Janssen Biotech, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Daniel Lee Delo, MD?

Tedicare shows public-source Medicare data for Daniel Lee Delo, MD (NPI 1114128618), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Daniel Lee Delo, MD have ACO affiliation data?

Daniel Lee Delo, MD is shown with ACO affiliation data for CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Daniel Lee Delo, MD?

Daniel Lee Delo, MD is linked to CAROLINA ARTHRITIS ASSOCIATES, P.A. (billing NPI 1427010081) in the available physician profile data.

Does Daniel Lee Delo, MD have Open Payments data?

Daniel Lee Delo, MD has 22 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.